Pharmaceutical Analytical Testing Outsourcing Market to Expand at 8.81% CAGR, Expected to Hit USD 9.74 Billion by 2032

The demand for external development knowledge and labour support from pharmaceutical and biotech businesses for their potential compounds

US, NY, UNITED STATES, March 17, 2025 /EINPresswire.com/ -- The global pharmaceutical analytical testing outsourcing market has been experiencing significant growth, driven by factors such as increasing R&D investments, stringent regulatory requirements, and the rising complexity of pharmaceutical products.

Pharmaceutical Analytical Testing Outsourcing Market Growth Size was valued at USD 4.56 billion in 2023. The pharmaceutical analytical testing outsourcing market industry is projected to grow from USD 4.95 Billion in 2024 to USD 9.74 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.81% during the forecast period (2024 - 2032). The market drivers for the expansion of the market are innovations in the pharmaceutical sector, a growing emphasis on regulation, safety, and quality, an increase in end users, and the cost advantages of outsourcing.

Top Pharmaceutical Analytical Testing Outsourcing Companies

Boston Analytical (New Hampshire)

West Pharmaceutical Services, Inc. (U.S.)

Exova Group PLC (U.K.)

Source BioScience (U.K.)

Pace Analytical Services, Inc. (U.S.)

Merck KGaA (Germany), WuXi AppTec (US)

Toxikon (US), Eurofins Scientific (Belgium)

Intertek Group Plc (U.K.)

Eurofins Scientific (Luxembourg)

West Pharmaceutical Services Inc. (U.S.)

Charles River Laboratories International, Inc (U.S.)

SGS SA (U.K.)

Pharmaceutical Product Development, LLC (U.S.)

Source BioScience (U.K.)

WuXi AppTec (U.S.)

Get Free Sample PDF Copy of This Report - https://www.marketresearchfuture.com/sample_request/7188

Additionally, the market will experience significant expansion as a result of the increasing demand for biosimilars and biopharmaceuticals. For instance, it is predicted that the development of new biosimilars will result in consumer savings of up to USD 250 billion and increase access to biological therapies for an additional 1.2 million patients by 2025, according to a study titled "Expected Impact of Biosimilars on the Pharmaceutical Companies" that was published in the Iranian Journal of Medical Sciences in August 2021.

𝖨𝗇𝖽𝗎𝗌𝗍𝗋𝗒 𝖣𝖾𝗍𝖺𝗂𝗅𝖾𝖽 𝖲𝖾𝗀𝗆𝖾𝗇𝗍𝖺𝗍𝗂𝗈𝗇:

Pharmaceutical Analytical Testing Outsourcing Market Segmentation

Pharmaceutical Analytical Testing Outsourcing Product Outlook (USD Billion, 2019-2030)

Finished Products

Active Pharmaceutical ingredients

Pharmaceutical Analytical Testing Outsourcing Services Outlook (USD Billion, 2019-2030)

Bioanalytical Testing

Stability Testing

Method Development & Validation

Others

Pharmaceutical Analytical Testing Outsourcing End User Outlook (USD Billion, 2019-2030)

Biopharmaceutical Companies

Biotechnology Industry

Pharmaceutical

Pharmaceutical Analytical Testing Outsourcing Regional Outlook (USD Billion, 2019-2030)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Australia

Rest of Asia-Pacific

Rest of the World

Middle East

Africa

Latin America

The Pharmaceutical Analytical Testing Outsourcing Market data, based on end-user, includes Biopharmaceutical Companies, Biotechnology Industry and Pharmaceutical. The pharmaceutical segment dominated the pharmaceutical analytical testing outsourcing market revenue for pharmaceutical analytical testing outsourcing in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Many clinical trials are conducted on pharmaceutical goods with the goal of evaluating various aspects of a medicine. Several medium-sized and smaller pharmaceutical firms do not have the capability of internal testing facilities. These businesses can concentrate on core manufacturing by outsourcing pharmaceutical analytical testing.

Buy Now –

https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=7188

Key Benefits:

Cost Efficiency

Reduces capital investment in expensive analytical equipment and laboratory infrastructure.

Minimizes operational costs related to staffing, training, and compliance.

Allows companies to focus on core competencies while outsourcing specialized testing needs.

Access to Advanced Technologies & Expertise

Provides access to state-of-the-art analytical instruments and techniques.

Ensures testing is conducted by highly trained professionals with expertise in regulatory compliance and quality control.

Facilitates the use of advanced methodologies such as chromatography, spectroscopy, and molecular testing.

Regulatory Compliance & Quality Assurance

Ensures compliance with global regulatory standards (e.g., FDA, EMA, ICH, USP).

Reduces the risk of regulatory issues and product recalls.

Provides detailed and validated analytical reports that meet industry requirements.

Faster Time-to-Market

Speeds up drug development processes by leveraging external expertise.

Reduces delays associated with setting up in-house testing facilities.

Helps in meeting tight deadlines for clinical trials and regulatory submissions.

Scalability & Flexibility

Allows pharmaceutical companies to scale testing services based on project needs.

Provides flexibility to handle peak testing demands without additional in-house investments.

Offers a wide range of testing services, including stability testing, method development, and bioanalytical testing.

Risk Mitigation & Data Integrity

Reduces the risk of internal testing errors and non-compliance.

Ensures data integrity with validated methodologies and quality assurance protocols.

Enhances credibility and reliability of test results for regulatory submissions.

Global Reach & Market Expansion

Helps pharmaceutical companies expand into new markets by ensuring product compliance with regional regulatory standards.

Provides access to international laboratories with localized expertise.

Facilitates collaboration with global CROs and contract development and manufacturing organizations (CDMOs).

Read More Details - https://www.marketresearchfuture.com/reports/pharmaceutical-analytical-testing-outsourcing-market-7188

𝖮𝗍𝗁𝖾𝗋 𝖫𝖺𝗍𝖾𝗌𝗍 𝖧𝖾𝖺𝗅𝗍𝗁𝖼𝖺𝗋𝖾 𝖳𝗋𝖾𝗇𝖽𝗂𝗇𝗀 𝖨𝗇𝗌𝗂𝗀𝗁𝗍𝗌

Swab Viral Transport Medium Market: https://www.marketresearchfuture.com/reports/swab-viral-transport-medium-market-27891

Swine Health Market: https://www.marketresearchfuture.com/reports/swine-health-market-43512

Synthetic Cannabinoids Market: https://www.marketresearchfuture.com/reports/synthetic-cannabinoids-market-39829

Targeted Cancer Therapies Market: https://www.marketresearchfuture.com/reports/targeted-cancer-therapies-market-27895

Technetium 99M Market: https://www.marketresearchfuture.com/reports/technetium-99m-market-32698

Telehealth Service Market: https://www.marketresearchfuture.com/reports/telehealth-service-market-43509

Telepsychiatry Market: https://www.marketresearchfuture.com/reports/telepsychiatry-market-42418

Testosterone Replacement Therapy Market: https://www.marketresearchfuture.com/reports/testosterone-replacement-therapy-market-32722

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Market Research Future
Market Research Future
+ +1 855-661-4441
email us here
Visit us on social media:
Facebook
X
LinkedIn